Sphygmomanometer Market (By Product: Electronic Sphygmomanometer, Aneroid Sphygmomanometer, Mercury Sphygmomanometer; By Operation: Electric, Manual, Automatic, Semi-automatic; By Configuration: Portable, Desk Mounted, Floor Standing, Wall Mounted; By End User: Hospitals, Ambulatory Surgical Centers & Clinics, Home Healthcare, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
The global sphygmomanometer market size was USD 2.62 billion in 2023, accounted for USD 2.85 billion in 2024, and is expected to reach around USD 6.19 billion by 2033, expanding at a CAGR of 9% from 2024 to 2033.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
The U.S. sphygmomanometer market size was estimated at USD 630 billion in 2023 and is predicted to be worth around USD 1,580 billion by 2033, at a CAGR of 9.6% from 2024 to 2033.
Because of its highly regulated and established healthcare system, North America held the greatest revenue share of more than 34.34% in 2023. Increasing investments in the development of accurate and effective BP monitors is projected to contribute to the growth of the blood pressure monitoring device business in the future years. Furthermore, new product releases and technology improvements are projected to fuel market expansion. For example, Hillrom announced the commercial debut of the Welch Allyn Spot Vital Signs 4400 in February 2020, which is an easy-to-use next-generation vital signs equipment designed to enhance hypertension identification in ambulatory and emergency department settings.
Asia-Pacific, on the other hand, is predicted to rise rapidly throughout the forecast period due to the availability of unexplored potential, rising hypertension prevalence and rising awareness levels. Rapidly improved healthcare facilities, as well as an increase in the number of misdiagnosed driving regional market expansion. Government attempts to raise public awareness, as well as a fast rising target disease population base, are all contributing to the lucrative growth of the BP monitoring devices market in this area.
For example, in May 2018, the Indian Council of Medical Research (ICMR) launched the "May Measurement Month 2018" campaign in partnership with the Public Health Foundation of India to raise awareness about blood pressure, which is the main cause of mortality and morbidity in India.
Market Overview
A sphygmomanometer is a device used to measure blood pressure by detecting the force of the blood in the heart. For individuals with heart problems, it is critical to monitor blood pressure with a sphygmomanometer. A single device may measure many metrics, including pulse rate and heartbeat rate, in addition to blood pressure. Sphygmomanometers are cheap, long-lasting, lightweight, and portable. The rising prevalence of chronic disorders such as hypertension and ischemic heart disease is propelling the industry forward.
The sphygmomanometer is made up of a rubber cup wrapped around the arm, a bulb to inate the cup, a valve to release the pressure, and a measuring device to measure the pressure of the cup. An oscillometric measuring method is used by a digital or electronic sphygmomanometer. It is simple to use, battery-powered, automated, and devoid of mercury. Manual, automated, wrist, upper arm, neonatal, and paediatrics sphygmomanometers are examples of digital sphygmomanometers. Wrist and automated digital sphygmomanometers are the most regularly utilised.
The rise in the incidence of chronic illnesses such as diabetes, hypertension, and ischemic heart disease is one of the primary reasons driving market expansion. According to the World Health Organization (WHO), an estimated 1.13 billion people worldwide had hypertension in 2019, and cardiovascular disease (CVDs) is the leading cause of mortality worldwide, claiming an estimated 17.9 million lives per year.
Long-term blood pressure management and monitoring is required for individuals at risk of cardiovascular problems; this factor is expected to drive market growth throughout the forecast period. Furthermore, technological improvements in the manufacture of mobile and wireless sphygmomanometers are expected to propel market expansion during the forecast period. The overall market development may be ascribed to expanding healthcare awareness, an ageing population, and technological improvements.
Furthermore, increased activities by governmental and private organisations to enhance healthcare throughout the world are fueling the market's rise.
The global sphygmomanometer market is predicted to develop significantly as a result of the evolution of improved sphygmomanometers, rising innovations in sphygmomanometer devices, and increased usage of sphygmomanometer for self-monitoring to limit the risk of infection. The market will be hampered by a decline in the use of mercury thermometers and an increase in the use of blood pressure monitors by healthcare providers that carry numerous diseases and germs. The development of a cloud-based healthcare system is a component generating market growth opportunities.
Report Coverage | Details |
Market Size in 2023 | USD 3.14 Billion |
Market Size in 2024 | USD 3.14 Billion |
Market Size by 2033 | USD 3.14 Billion |
Growth Rate from 2024 to 2033 | CAGR of 9% |
Base Year | 2023 |
Forecast Period | 2024 to 2033 |
Segments Covered | Product, Operation, Configuration, and End User |
Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Increasing incidences of hypertension
Advancements such as mobile-based bp monitoring systems
Due to its increasing demand in 2023, the aneroid BP monitors/sphygmomanometers segment has held the highest market share at more than 42.0%. Technological developments, together with new product introductions, are projected to increase global demand for sphygmomanometers. Demand for digital sphygmomanometers is predicted to grow at a rapid pace due to benefits such as accuracy and convenience of use.
Furthermore, continual technical advancements in the consumer healthcare segment, such as innovations in wearable technology, applications, and mobiles, the falling average selling price for retailers and manufacturers, and increased penetration in the professional market, are driving company expansion. Microlife WatchBP home A, QardioArm, LifeSource Sophisticated one-step auto inflate blood pressure monitor, and Omron healthcare's iHealth blood pressure monitor are examples of technologically advanced digital BP monitors on the market.
Blood pressure cuffs are predicted to expand at a substantial rate throughout the forecast period, owing to increased use of blood pressure monitors and the rising prevalence of high blood pressure. These cuffs are available in a variety of sizes depending on the patient. There are two sorts of cuffs on the market: disposable and reusable. The disposable category, in particular, is expected to rise at a rapid CAGR due to rising use of eco-friendly goods and growing worry over hospital-based cross-contamination occurrences.
The end-use categories examined in the blood pressure monitoring devices market include hospitals and clinics, ambulatory surgery centres, and home healthcare. Due to the availability of a broad patient pool, hospitals and clinics accounted for the biggest revenue share as of 2023. The desire for cost-effective, quick, and accurate diagnostic tools for better health outcomes is driving the use of blood pressure monitoring devices.
Over the projection period, home healthcare is expected to grow at a healthy CAGR of roughly 12.6%. The cost-effectiveness of this alternative option for BP monitoring, along with the availability of smart wearables that allow mobility, is projected to fuel expansion. As a result, the trend toward independent living is likely to push the home healthcare industry. Ambulatory blood pressure monitoring (ABMP) is a method of measuring out-of-office blood pressure measurements at defined time intervals during a 24-hour period. ABPM provides a more accurate technique of predicting long-term cardiovascular disease outcomes.
Recent Developments
Market Segmentation
By Product
By Operation
By Configuration
By End-User
By Geography
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Sphygmomanometer Market
5.1. COVID-19 Landscape: Sphygmomanometer Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Sphygmomanometer Market, By Product
8.1. Sphygmomanometer Market, by Product, 2024-2033
8.1.1. Electronic Sphygmomanometer
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Aneroid Sphygmomanometer
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Mercury Sphygmomanometer
8.1.3.1. Market Revenue and Forecast (2021-2033)
Chapter 9. Global Sphygmomanometer Market, By Operation
9.1. Sphygmomanometer Market, by Operation, 2024-2033
9.1.1. Electric
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Manual
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. Automatic
9.1.3.1. Market Revenue and Forecast (2021-2033)
9.1.4. Semi-automatic
9.1.4.1. Market Revenue and Forecast (2021-2033)
Chapter 10. Global Sphygmomanometer Market, By Configuration
10.1. Sphygmomanometer Market, by Configuration, 2024-2033
10.1.1. Portable
10.1.1.1. Market Revenue and Forecast (2021-2033)
10.1.2. Desk Mounted
10.1.2.1. Market Revenue and Forecast (2021-2033)
10.1.3. Floor Standing
10.1.3.1. Market Revenue and Forecast (2021-2033)
10.1.4. Wall Mounted
10.1.4.1. Market Revenue and Forecast (2021-2033)
Chapter 11. Global Sphygmomanometer Market, By End-User
11.1. Sphygmomanometer Market, by End-User, 2024-2033
11.1.1. Hospitals
11.1.1.1. Market Revenue and Forecast (2021-2033)
11.1.2. Ambulatory Surgical Centers & Clinics
11.1.2.1. Market Revenue and Forecast (2021-2033)
11.1.3. Home Healthcare
11.1.3.1. Market Revenue and Forecast (2021-2033)
11.1.4. Others
11.1.4.1. Market Revenue and Forecast (2021-2033)
Chapter 12. Global Sphygmomanometer Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2021-2033)
12.1.2. Market Revenue and Forecast, by Operation (2021-2033)
12.1.3. Market Revenue and Forecast, by Configuration (2021-2033)
12.1.4. Market Revenue and Forecast, by End-User (2021-2033)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2021-2033)
12.1.5.2. Market Revenue and Forecast, by Operation (2021-2033)
12.1.5.3. Market Revenue and Forecast, by Configuration (2021-2033)
12.1.5.4. Market Revenue and Forecast, by End-User (2021-2033)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2021-2033)
12.1.6.2. Market Revenue and Forecast, by Operation (2021-2033)
12.1.6.3. Market Revenue and Forecast, by Configuration (2021-2033)
12.1.6.4. Market Revenue and Forecast, by End-User (2021-2033)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2021-2033)
12.2.2. Market Revenue and Forecast, by Operation (2021-2033)
12.2.3. Market Revenue and Forecast, by Configuration (2021-2033)
12.2.4. Market Revenue and Forecast, by End-User (2021-2033)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2021-2033)
12.2.5.2. Market Revenue and Forecast, by Operation (2021-2033)
12.2.5.3. Market Revenue and Forecast, by Configuration (2021-2033)
12.2.5.4. Market Revenue and Forecast, by End-User (2021-2033)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2021-2033)
12.2.6.2. Market Revenue and Forecast, by Operation (2021-2033)
12.2.6.3. Market Revenue and Forecast, by Configuration (2021-2033)
12.2.6.4. Market Revenue and Forecast, by End-User (2021-2033)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2021-2033)
12.2.7.2. Market Revenue and Forecast, by Operation (2021-2033)
12.2.7.3. Market Revenue and Forecast, by Configuration (2021-2033)
12.2.7.4. Market Revenue and Forecast, by End-User (2021-2033)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2021-2033)
12.2.8.2. Market Revenue and Forecast, by Operation (2021-2033)
12.2.8.3. Market Revenue and Forecast, by Configuration (2021-2033)
12.2.8.4. Market Revenue and Forecast, by End-User (2021-2033)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2021-2033)
12.3.2. Market Revenue and Forecast, by Operation (2021-2033)
12.3.3. Market Revenue and Forecast, by Configuration (2021-2033)
12.3.4. Market Revenue and Forecast, by End-User (2021-2033)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2021-2033)
12.3.5.2. Market Revenue and Forecast, by Operation (2021-2033)
12.3.5.3. Market Revenue and Forecast, by Configuration (2021-2033)
12.3.5.4. Market Revenue and Forecast, by End-User (2021-2033)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2021-2033)
12.3.6.2. Market Revenue and Forecast, by Operation (2021-2033)
12.3.6.3. Market Revenue and Forecast, by Configuration (2021-2033)
12.3.6.4. Market Revenue and Forecast, by End-User (2021-2033)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2021-2033)
12.3.7.2. Market Revenue and Forecast, by Operation (2021-2033)
12.3.7.3. Market Revenue and Forecast, by Configuration (2021-2033)
12.3.7.4. Market Revenue and Forecast, by End-User (2021-2033)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2021-2033)
12.3.8.2. Market Revenue and Forecast, by Operation (2021-2033)
12.3.8.3. Market Revenue and Forecast, by Configuration (2021-2033)
12.3.8.4. Market Revenue and Forecast, by End-User (2021-2033)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2021-2033)
12.4.2. Market Revenue and Forecast, by Operation (2021-2033)
12.4.3. Market Revenue and Forecast, by Configuration (2021-2033)
12.4.4. Market Revenue and Forecast, by End-User (2021-2033)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2021-2033)
12.4.5.2. Market Revenue and Forecast, by Operation (2021-2033)
12.4.5.3. Market Revenue and Forecast, by Configuration (2021-2033)
12.4.5.4. Market Revenue and Forecast, by End-User (2021-2033)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2021-2033)
12.4.6.2. Market Revenue and Forecast, by Operation (2021-2033)
12.4.6.3. Market Revenue and Forecast, by Configuration (2021-2033)
12.4.6.4. Market Revenue and Forecast, by End-User (2021-2033)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2021-2033)
12.4.7.2. Market Revenue and Forecast, by Operation (2021-2033)
12.4.7.3. Market Revenue and Forecast, by Configuration (2021-2033)
12.4.7.4. Market Revenue and Forecast, by End-User (2021-2033)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2021-2033)
12.4.8.2. Market Revenue and Forecast, by Operation (2021-2033)
12.4.8.3. Market Revenue and Forecast, by Configuration (2021-2033)
12.4.8.4. Market Revenue and Forecast, by End-User (2021-2033)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2021-2033)
12.5.2. Market Revenue and Forecast, by Operation (2021-2033)
12.5.3. Market Revenue and Forecast, by Configuration (2021-2033)
12.5.4. Market Revenue and Forecast, by End-User (2021-2033)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2021-2033)
12.5.5.2. Market Revenue and Forecast, by Operation (2021-2033)
12.5.5.3. Market Revenue and Forecast, by Configuration (2021-2033)
12.5.5.4. Market Revenue and Forecast, by End-User (2021-2033)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2021-2033)
12.5.6.2. Market Revenue and Forecast, by Operation (2021-2033)
12.5.6.3. Market Revenue and Forecast, by Configuration (2021-2033)
12.5.6.4. Market Revenue and Forecast, by End-User (2021-2033)
Chapter 13. Company Profiles
13.1. A & D Company (India)
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Welch Allyn (U.S.)
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Koninklijke Philips N.V. (Netherlands)
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. General Electric (U.S.)
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Omron (Japan)
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Beurer GmbH (Germany)
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Paul Hartmann AG (Germany)
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Microlife Corporation (Switzerland)
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. American Diagnostic (U.S.)
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Rossmax International (Japan)
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client